# Phase II Study of DCVAC/PCa After Primary Radiotherapy for Patients With High Risk Localized Prostate Cancer

> **NCT02107430** · PHASE2 · COMPLETED · sponsor: **SOTIO a.s.** · enrollment: 62 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **BIOLOGICAL:** Dendritic Cells DCVAC/PCa
- **RADIATION:** Standard radiotherapy

## Key facts

- **NCT ID:** NCT02107430
- **Lead sponsor:** SOTIO a.s.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2013-09
- **Final completion:** 2018-10
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2018-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02107430

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02107430, "Phase II Study of DCVAC/PCa After Primary Radiotherapy for Patients With High Risk Localized Prostate Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02107430. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*